Designs specific human protein molecules using structure-guided protein engineering, directed evolution and enzymology. Generates research-tool ligands and protein-based drug candidates to translate academic discoveries into therapies for ischemia–reperfusion injury, thrombosis and COVID-19, targeting high unmet medical needs.